About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Study of LY3471851 in Participants With Psoriasis

A Study of LY3471851 in Participants With Psoriasis

NCT04119557·24 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Nektar Therapeutics

With

Eli Lilly and Company

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Have a confirmed diagnosis of psoriasis for at least 6 months
Have active psoriasis plaques according to study- specific criteria
Be willing and able to undergo skin biopsies

You may not be if

Have received certain topical medications for psoriasis within 14 days prior to baseline
Have received certain systemic medications for psoriasis within 4 weeks prior to baseline
Have received LY3471851 previously

The record

StatusCompleted

PhasePhase 1

Taking part30

StartedNov 2019

UpdatedFeb 20, 2024

Conditions

Where24

Arkansas Research Trials, LLC
North Little Rock, Arkansas, United States
California Dermatology & Clinical Research Institute
Encinitas, California, United States
Center For Dermatology Clinical Research, Inc.
Fremont, California, United States